| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Gastrointestinal Stromal Tumor | |||||
| Sarcoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Gastrointestinal Stromal Tumors | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Connective and Soft Tissue | |||||
| 4 | Interventions listed in this trial | ||||
| alvocidib | |||||
| doxorubicin hydrochloride | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Doxorubicin | |||||
| Flavopiridol | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antibiotics, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Enzyme Inhibitors | |||||
| Growth Inhibitors | |||||
| Growth Substances | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protein Kinase Inhibitors | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Memorial Sloan-Kettering Cancer Center | |||||
| National Cancer Institute (NCI) | |||||
|
